Ratain MJ - Search Results

1

Relationship of EGFR mutations, expression, amplification, and polymorphisms to epidermal growth factor receptor inhibitors in the NCI60 cell lines.

Liu W, Wu X, Zhang W, Montenegro RC, Fackenthal DL, Spitz JA, Huff LM, Innocenti F, Das S, Cook EH Jr, Cox NJ, Bates SE, Ratain MJ. Liu W, et al. Among authors: ratain mj. Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6788-95. doi: 10.1158/1078-0432.CCR-07-0547. Clin Cancer Res. 2007. PMID: 18006781

2

Correspondence re: Raida, M. et al., prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5'-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)-related toxicity compared with controls.

Innocenti F, Ratain MJ. Innocenti F, et al. Among authors: ratain mj. Clin Cancer Res. 2002 May;8(5):1314; author reply 1315-6. Clin Cancer Res. 2002. PMID: 12006555 No abstract available.

3

In vitro characterization of hepatic flavopiridol metabolism using human liver microsomes and recombinant UGT enzymes.

Ramírez J, Iyer L, Journault K, Bélanger P, Innocenti F, Ratain MJ, Guillemette C. Ramírez J, et al. Among authors: ratain mj. Pharm Res. 2002 May;19(5):588-94. doi: 10.1023/a:1015341726183. Pharm Res. 2002. PMID: 12069159

4

Haplotype structure of the UDP-glucuronosyltransferase 1A1 promoter in different ethnic groups.

Innocenti F, Grimsley C, Das S, Ramírez J, Cheng C, Kuttab-Boulos H, Ratain MJ, Di Rienzo A. Innocenti F, et al. Among authors: ratain mj. Pharmacogenetics. 2002 Dec;12(9):725-33. doi: 10.1097/00008571-200212000-00006. Pharmacogenetics. 2002. PMID: 12464801

5

Interethnic difference in the allelic distribution of human epidermal growth factor receptor intron 1 polymorphism.

Liu W, Innocenti F, Chen P, Das S, Cook EH Jr, Ratain MJ. Liu W, et al. Among authors: ratain mj. Clin Cancer Res. 2003 Mar;9(3):1009-12. Clin Cancer Res. 2003. PMID: 12631599

6

Irinotecan treatment in cancer patients with UGT1A1 polymorphisms.

Innocenti F, Ratain MJ. Innocenti F, et al. Among authors: ratain mj. Oncology (Williston Park). 2003 May;17(5 Suppl 5):52-5. Oncology (Williston Park). 2003. PMID: 12800608 Review.

7

A pharmacogenetic study of uridine diphosphate-glucuronosyltransferase 2B7 in patients receiving morphine.

Sawyer MB, Innocenti F, Das S, Cheng C, Ramírez J, Pantle-Fisher FH, Wright C, Badner J, Pei D, Boyett JM, Cook E Jr, Ratain MJ. Sawyer MB, et al. Among authors: ratain mj. Clin Pharmacol Ther. 2003 Jun;73(6):566-74. doi: 10.1016/S0009-9236(03)00053-5. Clin Pharmacol Ther. 2003. PMID: 12811366 Clinical Trial.

8

UGT pharmacogenomics: implications for cancer risk and cancer therapeutics.

Desai AA, Innocenti F, Ratain MJ. Desai AA, et al. Among authors: ratain mj. Pharmacogenetics. 2003 Aug;13(8):517-23. doi: 10.1097/01.fpc.0000054116.14659.e5. Pharmacogenetics. 2003. PMID: 12893990

9

Pharmacogenomics: road to anticancer therapeutics nirvana?

Desai AA, Innocenti F, Ratain MJ. Desai AA, et al. Among authors: ratain mj. Oncogene. 2003 Sep 29;22(42):6621-8. doi: 10.1038/sj.onc.1206958. Oncogene. 2003. PMID: 14528287

10

Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan.

Innocenti F, Undevia SD, Iyer L, Chen PX, Das S, Kocherginsky M, Karrison T, Janisch L, Ramírez J, Rudin CM, Vokes EE, Ratain MJ. Innocenti F, et al. Among authors: ratain mj. J Clin Oncol. 2004 Apr 15;22(8):1382-8. doi: 10.1200/JCO.2004.07.173. Epub 2004 Mar 8. J Clin Oncol. 2004. PMID: 15007088

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

575 results

Search Page

Filters